Virtual Incision is developing a first-of-its-kind, miniaturized robot for general surgery abdominal procedures.

About Us

Virtual Incision Corporation is a privately-held medical device company focused on developing an advanced, miniaturized robot for general surgery abdominal procedures, such as colon resections.

Propelled by the knowledge that colorectal and lower gastrointestinal procedures are the fastest growing in the United States, Dr. Dmitry Oleynikov and Dr. Shane Farritor founded Virtual Incision in 2006.

The company is a spin-out of the University of Nebraska, where Dr. Dmitry Oleynikov and Dr. Shane Farritor are currently based. John Murphy joined Virtual Incision in 2012 and is based in Pleasanton, California.

Robot Prototypes
Comparative Medical Studies
Patents and Applications

John P. Murphy, MBA, MS

Chief Executive Officer

A global medical technology and health sciences executive, John Murphy has held leadership roles in large public companies, middle-market private equity businesses, and venture capital environments over the past 20 years. He holds graduate and undergraduate degrees in computer science and a MBA in international finance. John currently serves as the independent director of NeuWave Medical.

Shane M. Farritor, PhD, MS

Co-Founder & Chief Technology Officer

Dr. Shane Farritor holds a doctorate and master’s degree in Mechanical Engineering from MIT and is currently a faculty member at the University of Nebraska-Lincoln. Prior to his work at the university, Shane studied at the Kennedy Space Center, Goddard Space Flight Center, and the Jet Propulsion Laboratory.

Dmitry Oleynikov, MD FACS

Co-Founder & Chief Medical Officer

Dr. Dmitry Oleynikov is a general surgeon, advanced laparoscopic surgeon, robotic MIS surgeon, and professor of surgery at the University of Nebraska Medical Center (UNMC) in Omaha. He serves as the director of UNMC’s Center for Advanced Surgical Technology and is a board member of the Society of American Gastrointestinal Endoscopic Surgeons.

Contact Us

Virtual Incision’s robotically-assisted surgical device is an investigational device and is not commercially available.